Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brandon McCutcheon, MD
Spirair, CMO
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alabama Nasal and Sinus Center
Birmingham, Alabama, United States
- Breathe Clear Institute
Torrance, California, United States
- Kentuckiana Ear, Nose & Throat
Louisville, Kentucky, United States
- Sinus and Nasal Specialists of la
Baton Rouge, Louisiana, United States
- Tandem Clinical Research
Marrero, Louisiana, United States
- Albany Ent & Allergy Services, Pc
Albany, New York, United States
- Specialty Physicians
Bethlehem, Pennsylvania, United States
- Ear Nose Throat & Allergy Associates
Puyallup, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2023
- Primary completion
- 31 Mar 2027
- Completion
- 30 Jun 2027
- Last update posted
- 30 Mar 2026
- Registered enrollment
- 102
- Registry id
- NCT06163404
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.